Andrew Arno Oncocyte Corp (OCX) insider trading activity
Andrew Arno is Director of Oncocyte Corp. Currently has a direct ownership of 81,554 shares of OCX, which is worth approximately $189,205. The most recent transaction as insider was on Dec 26, 2024, when has been sold 12,500 shares (Common Stock, No Par Value) at a price of $2.11 per share, resulting in proceeds of $26,375. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
81.6K
18.1%
3M change
88.4%
12M change
Total Value Held
$189,205
Andrew Arno Transaction History
Also insider at
AA
Andrew Arno
Director
Irvine, CA